Completion of axillary dissection for a positive sentinel node: necessary or not?

Area of Science:

• Oncology
• Surgical Oncology
• Breast Cancer Research

Background:

• Sentinel lymph node excision is standard for axillary staging in breast cancer.
• Positive sentinel nodes typically lead to complete axillary node dissection, increasing morbidity.
• Current standard of care involves axillary node dissection after positive sentinel node biopsy.

Purpose of the Study:

• To review data on outcomes of omitting axillary node dissection after positive sentinel nodes.
• To evaluate models for predicting nonsentinel node status.
• To assess the morbidity associated with axillary operations.

Main Methods:

• Review of sentinel lymph node trial data.
• Analysis of case series reports on omitting axillary node dissection.
• Examination of predictive models for nonsentinel node metastasis.
• Assessment of axillary operation-related morbidity.

Main Results:

• Sentinel node excision alone shows a lower local recurrence rate compared to standard axillary dissection.
• Systemic therapy may contribute to sterilizing the axilla, reducing the need for further dissection.
• An approximate 10% false-negative rate exists for sentinel node biopsy.

Conclusions:

• Omitting axillary node dissection may be appropriate for selected breast cancer patients with positive sentinel nodes.
• Further randomized clinical trials are necessary to confirm the safety and efficacy of this approach.
• Evidence suggests potential for reduced morbidity by avoiding complete axillary dissection in select cases.